invivo MAb anti-mouse CD45.2

貨號:

BE0300

品牌:

Bioxcell

規格:

mg

概述

別名:

MAb anti-mouse CD45.2

克隆類(lèi)型:

Monoclonal Antibodies

詳述

抗體應用:

未定義

InVivoMab Antibodies來(lái)源：

20多年來(lái)，科學(xué)家一直相信bioxcell是體內功能級抗體的來(lái)源。我們牢記這一責任，始終致力于一個(gè)目標：生產(chǎn)高質(zhì)量、價(jià)值高的抗體。我們對科學(xué)家的堅定承諾激勵我們創(chuàng )造和優(yōu)化一種專(zhuān)利的體內抗體制造方法，具有顯著(zhù)的優(yōu)勢，直接使我們的客戶(hù)受益。? ? ? ? ? ? ? ? ?

Bio X Cell產(chǎn)品特點(diǎn)：

我們優(yōu)化的專(zhuān)利抗體制造方法確保超純抗體溶液不添加蛋白質(zhì)或化學(xué)物質(zhì)。使用SDS-PAGE對每個(gè)批次的純度進(jìn)行QC測試。

超低內毒素水平。我們的InVivoMAb產(chǎn)品≤2EU/mg，InVivoPlus產(chǎn)品≤1EU/mg。如果需要低于1EU/mg的內毒素水平，請聯(lián)系我們的技術(shù)支持以獲取詳細信息。

貨號	名稱(chēng)	?	克隆	反應性	抗原	宿主	同型	免疫原
BE0300-100MG	InVivoMAb anti-mouse CD45.2	?	104.2	mouse	CD45.2	mouse	IgG2a, κ	B10.S mouse thymocytes and splenocytes
BE0300-1MG	InVivoMAb anti-mouse CD45.2	?	104.2	mouse	CD45.2	mouse	IgG2a, κ	B10.S mouse thymocytes and splenocytes
BE0300-5MG	InVivoMAb anti-mouse CD45.2	?	104.2	mouse	CD45.2	mouse	IgG2a, κ	B10.S mouse thymocytes and splenocytes
BE0300-25MG	InVivoMAb anti-mouse CD45.2	?	104.2	mouse	CD45.2	mouse	IgG2a, κ	B10.S mouse thymocytes and splenocytes
BE0300-50MG	InVivoMAb anti-mouse CD45.2	?	104.2	mouse	CD45.2	mouse	IgG2a, κ	B10.S mouse thymocytes and splenocytes
BE0301-100MG	InVivoMAb human IgG2 isotype control	?	n/a	n/a	Unknown Specificify	human?	IgG2	?
BE0301-1MG	InVivoMAb human IgG2 isotype control	?	n/a	n/a	Unknown Specificify	human?	IgG2	?
BE0301-5MG	InVivoMAb human IgG2 isotype control	?	n/a	n/a	Unknown Specificify	human?	IgG2	?
BE0301-25MG	InVivoMAb human IgG2 isotype control	?	n/a	n/a	Unknown Specificify	human?	IgG2	?
BE0301-50MG	InVivoMAb human IgG2 isotype control	?	n/a	n/a	Unknown Specificify	human?	IgG2	?
BE0302-100MG	InVivoMAb anti-mouse CD20	?	AISB12	mouse	CD20	rat	IgG2a, κ	Full length mouse CD20 protein
BE0302-25MG	InVivoMAb anti-mouse CD20	?	AISB12	mouse	CD20	rat	IgG2a, κ	Full length mouse CD20 protein
BE0302-50MG	InVivoMAb anti-mouse CD20	?	AISB12	mouse	CD20	rat	IgG2a, κ	Full length mouse CD20 protein
BE0303-100MG	InVivoMAb anti-mouse IL-17F	?	MM17F8F5.1A9	mouse	IL-17F	mouse	IgG1, κ	Mouse IL-17F
BE0303-1MG	InVivoMAb anti-mouse IL-17F	?	MM17F8F5.1A9	mouse	IL-17F	mouse	IgG1, κ	Mouse IL-17F
BE0303-5MG	InVivoMAb anti-mouse IL-17F	?	MM17F8F5.1A9	mouse	IL-17F	mouse	IgG1, κ	Mouse IL-17F
BE0303-25MG	InVivoMAb anti-mouse IL-17F	?	MM17F8F5.1A9	mouse	IL-17F	mouse	IgG1, κ	Mouse IL-17F
BE0303-50MG	InVivoMAb anti-mouse IL-17F	?	MM17F8F5.1A9	mouse	IL-17F	mouse	IgG1, κ	Mouse IL-17F
BE0304-100MG	InVivoMAb anti-mouse BTLA (CD272)	?	6F7	mouse	BTLA (CD272)	mouse	IgG1, κ	Ig domain of C57BL/6 mouse BTLA
BE0304-1MG	InVivoMAb anti-mouse BTLA (CD272)	?	6F7	mouse	BTLA (CD272)	mouse	IgG1, κ	Ig domain of C57BL/6 mouse BTLA
BE0304-5MG	InVivoMAb anti-mouse BTLA (CD272)	?	6F7	mouse	BTLA (CD272)	mouse	IgG1, κ	Ig domain of C57BL/6 mouse BTLA
BE0304-25MG	InVivoMAb anti-mouse BTLA (CD272)	?	6F7	mouse	BTLA (CD272)	mouse	IgG1, κ	Ig domain of C57BL/6 mouse BTLA
BE0304-50MG	InVivoMAb anti-mouse BTLA (CD272)	?	6F7	mouse	BTLA (CD272)	mouse	IgG1, κ	Ig domain of C57BL/6 mouse BTLA
BE0305-100MG	InVivoMAb anti-mouse CLEC9A (CD370)	?	7H11	mouse	CLEC9A (CD370)	Rat	IgG1, κ	RBL-2H3 cells expressing mouse CLEC9A fused to an HA epitope
BE0305-1MG	InVivoMAb anti-mouse CLEC9A (CD370)	?	7H11	mouse	CLEC9A (CD370)	Rat	IgG1, κ	RBL-2H3 cells expressing mouse CLEC9A fused to an HA epitope
BE0305-5MG	InVivoMAb anti-mouse CLEC9A (CD370)	?	7H11	mouse	CLEC9A (CD370)	Rat	IgG1, κ	RBL-2H3 cells expressing mouse CLEC9A fused to an HA epitope
BE0305-25MG	InVivoMAb anti-mouse CLEC9A (CD370)	?	7H11	mouse	CLEC9A (CD370)	Rat	IgG1, κ	RBL-2H3 cells expressing mouse CLEC9A fused to an HA epitope
BE0305-50MG	InVivoMAb anti-mouse CLEC9A (CD370)	?	7H11	mouse	CLEC9A (CD370)	Rat	IgG1, κ	RBL-2H3 cells expressing mouse CLEC9A fused to an HA epitope
BE0306-100MG	InVivoMAb anti-human/monkey MHC class II (HLA-DR)	?	L243	human/monkey	MHC class II (HLA-DR)	Mouse	IgG2a, κ	Human lymphoblastoid B cell line RPMI 8866.9
BE0306-1MG	InVivoMAb anti-human/monkey MHC class II (HLA-DR)	?	L243	human/monkey	MHC class II (HLA-DR)	Mouse	IgG2a, κ	Human lymphoblastoid B cell line RPMI 8866.9
BE0306-5MG	InVivoMAb anti-human/monkey MHC class II (HLA-DR)	?	L243	human/monkey	MHC class II (HLA-DR)	Mouse	IgG2a, κ	Human lymphoblastoid B cell line RPMI 8866.9
BE0306-25MG	InVivoMAb anti-human/monkey MHC class II (HLA-DR)	?	L243	human/monkey	MHC class II (HLA-DR)	Mouse	IgG2a, κ	Human lymphoblastoid B cell line RPMI 8866.9
BE0306-50MG	InVivoMAb anti-human/monkey MHC class II (HLA-DR)	?	L243	human/monkey	MHC class II (HLA-DR)	Mouse	IgG2a, κ	Human lymphoblastoid B cell line RPMI 8866.9
BE0307-100MG	InVivoMAb anti-mouse CD16/CD32	?	2.4G2	mouse	CD16/CD32	Rat	IgG2b, κ	BALB/c mouse macrophage cell line J774
BE0307-5MG	InVivoMAb anti-mouse CD16/CD32	?	2.4G2	mouse	CD16/CD32	Rat	IgG2b, κ	BALB/c mouse macrophage cell line J774
BE0307-25MG	InVivoMAb anti-mouse CD16/CD32	?	2.4G2	mouse	CD16/CD32	Rat	IgG2b, κ	BALB/c mouse macrophage cell line J774
BE0307-50MG	InVivoMAb anti-mouse CD16/CD32	?	2.4G2	mouse	CD16/CD32	Rat	IgG2b, κ	BALB/c mouse macrophage cell line J774
BE0308-100MG	InVivoMAb anti-rat CD4	?	OX-38	rat	CD4	Mouse	IgG2a, κ	Rat thymocyte glycoproteins
BE0308-1MG	InVivoMAb anti-rat CD4	?	OX-38	rat	CD4	Mouse	IgG2a, κ	Rat thymocyte glycoproteins
BE0308-5MG	InVivoMAb anti-rat CD4	?	OX-38	rat	CD4	Mouse	IgG2a, κ	Rat thymocyte glycoproteins
BE0308-25MG	InVivoMAb anti-rat CD4	?	OX-38	rat	CD4	Mouse	IgG2a, κ	Rat thymocyte glycoproteins
BE0308-50MG	InVivoMAb anti-rat CD4	?	OX-38	rat	CD4	Mouse	IgG2a, κ	Rat thymocyte glycoproteins
BE0309-100MG	InVivoMAb anti-mouse CXCL9 (MIG)	?	MIG-2F5.5	mouse	CXCL9 (MIG)	Armenian hamster	IgG, κ	?
BE0309-1MG	InVivoMAb anti-mouse CXCL9 (MIG)	?	MIG-2F5.5	mouse	CXCL9 (MIG)	Armenian hamster	IgG, κ	?
BE0309-5MG	InVivoMAb anti-mouse CXCL9 (MIG)	?	MIG-2F5.5	mouse	CXCL9 (MIG)	Armenian hamster	IgG, κ	?
BE0309-25MG	InVivoMAb anti-mouse CXCL9 (MIG)	?	MIG-2F5.5	mouse	CXCL9 (MIG)	Armenian hamster	IgG, κ	?
BE0309-50MG	InVivoMAb anti-mouse CXCL9 (MIG)	?	MIG-2F5.5	mouse	CXCL9 (MIG)	Armenian hamster	IgG, κ	?
BE0310-100MG	InVivoMAb anti-mouse VISTA	?	13F3	mouse	VISTA	Armenian hamster	IgG	EL4 cells overexpressing mouse VISTA-RFP and then boosted with VISTA-Ig fusion protein
BE0310-1MG	InVivoMAb anti-mouse VISTA	?	13F3	mouse	VISTA	Armenian hamster	IgG	EL4 cells overexpressing mouse VISTA-RFP and then boosted with VISTA-Ig fusion protein
BE0310-5MG	InVivoMAb anti-mouse VISTA	?	13F3	mouse	VISTA	Armenian hamster	IgG	EL4 cells overexpressing mouse VISTA-RFP and then boosted with VISTA-Ig fusion protein
BE0310-25MG	InVivoMAb anti-mouse VISTA	?	13F3	mouse	VISTA	Armenian hamster	IgG	EL4 cells overexpressing mouse VISTA-RFP and then boosted with VISTA-Ig fusion protein
BE0310-50MG	InVivoMAb anti-mouse VISTA	?	13F3	mouse	VISTA	Armenian hamster	IgG	EL4 cells overexpressing mouse VISTA-RFP and then boosted with VISTA-Ig fusion protein
BE0311-100MG	InVivoMAb anti-mouse CD317 (BST2, PDCA-1)	?	927	mouse	CD317 (BST2, PDCA-1)	Rat	IgG2b, κ	Mouse type I IFN-producing cells
BE0311-1MG	InVivoMAb anti-mouse CD317 (BST2, PDCA-1)	?	927	mouse	CD317 (BST2, PDCA-1)	Rat	IgG2b, κ	Mouse type I IFN-producing cells
BE0311-5MG	InVivoMAb anti-mouse CD317 (BST2, PDCA-1)	?	927	mouse	CD317 (BST2, PDCA-1)	Rat	IgG2b, κ	Mouse type I IFN-producing cells
BE0311-25MG	InVivoMAb anti-mouse CD317 (BST2, PDCA-1)	?	927	mouse	CD317 (BST2, PDCA-1)	Rat	IgG2b, κ	Mouse type I IFN-producing cells
BE0311-50MG	InVivoMAb anti-mouse CD317 (BST2, PDCA-1)	?	927	mouse	CD317 (BST2, PDCA-1)	Rat	IgG2b, κ	Mouse type I IFN-producing cells
BE0312-100MG	InVivoMAb anti-mouse IFNγ	?	H22	mouse	IFNγ	Armenian hamster	IgG	Recombinant full-length murine IFNγ
BE0312-1MG	InVivoMAb anti-mouse IFNγ	?	H22	mouse	IFNγ	Armenian hamster	IgG	Recombinant full-length murine IFNγ
BE0312-5MG	InVivoMAb anti-mouse IFNγ	?	H22	mouse	IFNγ	Armenian hamster	IgG	Recombinant full-length murine IFNγ
BE0312-25MG	InVivoMAb anti-mouse IFNγ	?	H22	mouse	IFNγ	Armenian hamster	IgG	Recombinant full-length murine IFNγ
BE0312-50MG	InVivoMAb anti-mouse IFNγ	?	H22	mouse	IFNγ	Armenian hamster	IgG	Recombinant full-length murine IFNγ
BE0313-100MG	InVivoMAb anti-mouse IL-23 (p19)	?	G23-8	mouse?	IL-23 (p19)	Rat?	IgG1, κ	Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0313-25MG	InVivoMAb anti-mouse IL-23 (p19)	?	G23-8	mouse?	IL-23 (p19)	Rat?	IgG1, κ	Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0313-50MG	InVivoMAb anti-mouse IL-23 (p19)	?	G23-8	mouse?	IL-23 (p19)	Rat?	IgG1, κ	Insect cell-expressed, recombinant mouse IL-23 heterodimer
BE0314-100MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3D10	mouse	TIM-1 (CD365)	Rat?	IgG1, κ	Mouse TIM-1 (signal and IgV domains)/mouse IgG2a Fc fusion protein
BE0314-1MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3D10	mouse	TIM-1 (CD365)	Rat?	IgG1, κ	Mouse TIM-1 (signal and IgV domains)/mouse IgG2a Fc fusion protein
BE0314-5MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3D10	mouse	TIM-1 (CD365)	Rat?	IgG1, κ	Mouse TIM-1 (signal and IgV domains)/mouse IgG2a Fc fusion protein
BE0314-25MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3D10	mouse	TIM-1 (CD365)	Rat?	IgG1, κ	Mouse TIM-1 (signal and IgV domains)/mouse IgG2a Fc fusion protein
BE0314-50MG	InVivoMAb anti-mouse TIM-1 (CD365)	?	3D10	mouse	TIM-1 (CD365)	Rat?	IgG1, κ	Mouse TIM-1 (signal and IgV domains)/mouse IgG2a Fc fusion protein
BE0315-100MG	InVivoMAb anti-mouse IL-15	?	AIO.3	mouse	IL-15	Rat	IgG2a, κ	Recombinant mouse IL-15
BE0315-25MG	InVivoMAb anti-mouse IL-15	?	AIO.3	mouse	IL-15	Rat	IgG2a, κ	Recombinant mouse IL-15
BE0315-50MG	InVivoMAb anti-mouse IL-15	?	AIO.3	mouse	IL-15	Rat	IgG2a, κ	Recombinant mouse IL-15
BE0316-100MG	InVivoMAb anti-mouse CCR3 (CD193)	?	6S2-19-4	mouse	CCR3 (CD193)	Rat	IgG2b, λ	Y3 cells expressing full length mouse CCR3
BE0316-1MG	InVivoMAb anti-mouse CCR3 (CD193)	?	6S2-19-4	mouse	CCR3 (CD193)	Rat	IgG2b, λ	Y3 cells expressing full length mouse CCR3
BE0316-5MG	InVivoMAb anti-mouse CCR3 (CD193)	?	6S2-19-4	mouse	CCR3 (CD193)	Rat	IgG2b, λ	Y3 cells expressing full length mouse CCR3
BE0316-25MG	InVivoMAb anti-mouse CCR3 (CD193)	?	6S2-19-4	mouse	CCR3 (CD193)	Rat	IgG2b, λ	Y3 cells expressing full length mouse CCR3
BE0316-50MG	InVivoMAb anti-mouse CCR3 (CD193)	?	6S2-19-4	mouse	CCR3 (CD193)	Rat	IgG2b, λ	Y3 cells expressing full length mouse CCR3
BE0317-100MG	InVivoMAb anti-mouse CD38	?	NIMR5	mouse	CD38	Rat	IgG2a, κ	BCL1 plasma membrane glycoproteins
BE0317-1MG	InVivoMAb anti-mouse CD38	?	NIMR5	mouse	CD38	Rat	IgG2a, κ	BCL1 plasma membrane glycoproteins
BE0317-5MG	InVivoMAb anti-mouse CD38	?	NIMR5	mouse	CD38	Rat	IgG2a, κ	BCL1 plasma membrane glycoproteins
BE0317-25MG	InVivoMAb anti-mouse CD38	?	NIMR5	mouse	CD38	Rat	IgG2a, κ	BCL1 plasma membrane glycoproteins
BE0317-50MG	InVivoMAb anti-mouse CD38	?	NIMR5	mouse	CD38	Rat	IgG2a, κ	BCL1 plasma membrane glycoproteins
BE0318-100MG	InVivoMAb anti-human Ganglioside GD2	?	14G2a	human	Ganglioside GD2	Mouse	IgG2a, κ	Neuroblastoma cell line LAN-1
BE0318-1MG	InVivoMAb anti-human Ganglioside GD2	?	14G2a	human	Ganglioside GD2	Mouse	IgG2a, κ	Neuroblastoma cell line LAN-1
BE0318-5MG	InVivoMAb anti-human Ganglioside GD2	?	14G2a	human	Ganglioside GD2	Mouse	IgG2a, κ	Neuroblastoma cell line LAN-1
BE0318-25MG	InVivoMAb anti-human Ganglioside GD2	?	14G2a	human	Ganglioside GD2	Mouse	IgG2a, κ	Neuroblastoma cell line LAN-1
BE0318-50MG	InVivoMAb anti-human Ganglioside GD2	?	14G2a	human	Ganglioside GD2	Mouse	IgG2a, κ	Neuroblastoma cell line LAN-1

濃度：2-10 mg/m

l

儲存與安全

儲存:

4℃

關(guān)于我們

Wolcavi Biotech致力于干細胞免疫治療、分子生物學(xué) 、免疫學(xué)、體外診斷等相關(guān)領(lǐng)域的實(shí)驗需求產(chǎn)品開(kāi)發(fā)和銷(xiāo)售。主要產(chǎn)品有抗原抗體|無(wú)血清培養基|細胞培養耗材并代理銷(xiāo)售Abcam、Invitrogen(Gibco)、Roche、Sigma、R&D、Meridian等二十多家國外知名品牌。

聯(lián)系我們

北京市通州區金橋科技園景盛南二街12號納特園區
Phone: +86 010 8646 3560
Email: info@wolcavi.com

新聞

標簽

?
?
?
?
?

?
010-5944 6861

亚洲va在线va天堂va偷拍|99久久久久无码国产精品|一本久久a久久免费精品网站|午夜精品久久久久久毛片777|国产95在线 | 欧美|欧美一区二区三区高清在线|亚欧无码视频一区二区三区

亚洲va在线va天堂va偷拍|99久久久久无码国产精品|一本久久a久久免费精品网站|午夜精品久久久久久毛片777|国产95在线 | 欧美|欧美一区二区三区高清在线|亚欧无码视频一区二区三区

invivo MAb anti-mouse CD45.2